Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate?
作者信息
Ten Cate Hugo, Hemker H Coenraad
机构信息
Departments of Internal Medicine and Biochemistry, Cardiovascular Research Institute Maastricht (CARIM) and Thrombosis Expertise Center, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands
Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM) and Synapse, Maastricht University, Maastricht, The Netherlands.
出版信息
J Am Heart Assoc. 2016 Aug 8;5(8):e003553. doi: 10.1161/JAHA.116.003553.
Abstract
摘要
相似文献
1
Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate?
J Am Heart Assoc. 2016 Aug 8;5(8):e003553. doi: 10.1161/JAHA.116.003553.
2
[METABOLIC PROBLEMS OF ATHEROSCLEROSIS. III. ATHEROSCLEROSIS AND BLOOD COAGULATION].
Med Monatsschr. 1963 Sep;17:560-4.
3
Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.
Thromb Haemost. 2018 Feb;118(2):229-250. doi: 10.1160/TH17-07-0492. Epub 2018 Jan 29.
4
Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner.
PLoS One. 2013;8(2):e55784. doi: 10.1371/journal.pone.0055784. Epub 2013 Feb 7.
5
Targeting factor Xa and thrombin: impact on coagulation and beyond.
Thromb Haemost. 2014 Apr 1;111(4):625-33. doi: 10.1160/TH13-09-0730. Epub 2013 Dec 12.
6
Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammation.
Blood. 2009 Sep 24;114(13):2812-8. doi: 10.1182/blood-2009-01-200915. Epub 2009 Aug 3.
7
Coagulation pathways in atherothrombosis.
Trends Cardiovasc Med. 2002 Oct;12(7):317-24. doi: 10.1016/s1050-1738(02)00182-2.
8
Human cytomegalovirus infection and atherothrombosis.
J Thromb Thrombolysis. 2012 Feb;33(2):160-72. doi: 10.1007/s11239-011-0662-x.
9
Tissue factor in atherosclerosis and atherothrombosis.
Atherosclerosis. 2020 Aug;307:80-86. doi: 10.1016/j.atherosclerosis.2020.06.003. Epub 2020 Jul 3.
10
Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation.
Vascul Pharmacol. 2016 Jul;82:1-10. doi: 10.1016/j.vph.2015.10.009. Epub 2015 Nov 9.
引用本文的文献
1
Association between ex vivo thrombogenicity and ischemic outcome in off-pump coronary surgery.
Ann Med. 2025 Dec;57(1):2514079. doi: 10.1080/07853890.2025.2514079. Epub 2025 Jun 10.
2
Platelets, Biomarkers of Coagulation and Fibrinolysis, and Early Coronary Stent Thrombosis.
J Clin Med. 2024 Dec 26;14(1):56. doi: 10.3390/jcm14010056.
3
The Etiology of the Thrombotic Phenomena Involved in the Process of Coronary Artery Disease-What Is the Role of Thrombophilic Genes in the Development of This Pathology?
Int J Mol Sci. 2024 May 11;25(10):5228. doi: 10.3390/ijms25105228.
4
Single-Particle Plasmon Sensor to Monitor Proteolytic Activity in Real Time.
ACS Appl Opt Mater. 2023 Oct 4;1(10):1661-1669. doi: 10.1021/acsaom.3c00226. eCollection 2023 Oct 27.
5
The Contribution of Vascular Proteoglycans to Atherothrombosis: Clinical Implications.
Int J Mol Sci. 2023 Jul 24;24(14):11854. doi: 10.3390/ijms241411854.
6
Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases.
Front Cardiovasc Med. 2022 Nov 10;9:1033416. doi: 10.3389/fcvm.2022.1033416. eCollection 2022.
7
Quartz Crystal Microbalance-Based Aptasensors for Medical Diagnosis.
Micromachines (Basel). 2022 Sep 1;13(9):1441. doi: 10.3390/mi13091441.
8
Differential Inhibition of Platelet Reactivity by Dual Therapy With Aspirin and Low-Dose Rivaroxaban in Peripheral Arterial Disease: A Pilot Study.
Front Cardiovasc Med. 2022 May 6;9:865166. doi: 10.3389/fcvm.2022.865166. eCollection 2022.
9
Theranostic nanoparticles for the management of thrombosis.
Theranostics. 2022 Mar 14;12(6):2773-2800. doi: 10.7150/thno.70001. eCollection 2022.
10
Differences in thrombin and plasmin generation potential between East African and Western European adults: The role of genetic and non-genetic factors.
J Thromb Haemost. 2022 May;20(5):1089-1105. doi: 10.1111/jth.15657. Epub 2022 Feb 10.
本文引用的文献
1
Thrombin Generation Assay and Its Application in the Clinical Laboratory.
Clin Chem. 2016 May;62(5):699-707. doi: 10.1373/clinchem.2015.248625. Epub 2016 Mar 8.
2
Contact system revisited: an interface between inflammation, coagulation, and innate immunity.
J Thromb Haemost. 2016 Mar;14(3):427-37. doi: 10.1111/jth.13235. Epub 2016 Feb 9.
3
Inhibition of thrombin generation in human plasma by phospholipid transfer protein.
Thromb J. 2015 Jul 16;13:24. doi: 10.1186/s12959-015-0054-0. eCollection 2015.
4
The hypercoagulable profile of patients with stent thrombosis.
Heart. 2015 Jul;101(14):1126-32. doi: 10.1136/heartjnl-2014-306685. Epub 2015 May 21.
5
The application of thrombin generation in real life clinical situations.
Thromb Res. 2015 Jul;136(1):3-4. doi: 10.1016/j.thromres.2015.04.010. Epub 2015 Apr 14.
6
Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects.
Clin Res Cardiol Suppl. 2015 Apr;10(Suppl 1):21-5. doi: 10.1007/s11789-015-0074-0.
7
Diet and haemostasis - a comprehensive overview.
Blood Rev. 2015 Jul;29(4):231-41. doi: 10.1016/j.blre.2014.12.005. Epub 2014 Dec 20.
8
Re-evaluation of the anticoagulant properties of high-density lipoprotein-brief report.
Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):570-2. doi: 10.1161/ATVBAHA.114.304938. Epub 2014 Dec 30.
9
Associations Between Thrombin Generation and the Risk of Cardiovascular Disease in Elderly Patients: Results From the PROSPER Study.
J Gerontol A Biol Sci Med Sci. 2015 Aug;70(8):982-8. doi: 10.1093/gerona/glu228. Epub 2014 Dec 24.
10
The hemostatic system as a regulator of inflammation in atherosclerosis.
IUBMB Life. 2014 Nov;66(11):735-44. doi: 10.1002/iub.1333. Epub 2014 Dec 9.
Zotero 插件